uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Aliqopa
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004334
ATC code
-
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of adult patients with relapsed marginal zone lymphoma
MeSH:
Lymphoma, B-Cell, Marginal Zone
Group:
Antineoplastic agents
Active substances
copanlisib dihydrochloride
Marketing Authorisation Holder
Bayer AG
MAH
Aliqopa | uMedical